Xenon Pharmaceuticals (XENE) Other Accumulated Expenses (2013 - 2025)

Xenon Pharmaceuticals (XENE) has 13 years of Other Accumulated Expenses data on file, last reported at $966000.0 in Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $966000.0, up 35.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $966000.0 (up 35.29% YoY), and the FY2025 annual result was $966000.0, up 35.29% from the prior year.
• Other Accumulated Expenses advanced to $966000.0 in Q4 2025 per XENE's latest filing, from $935000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $1.1 million in Q2 2024 and troughed at $26000.0 in Q3 2021.
• A 5-year average of $418842.1 and a median of $282000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• On a YoY basis, Other Accumulated Expenses climbed as much as 1106.59% in 2024 and fell as far as 86.13% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $118000.0 in 2021, then soared by 188.98% to $341000.0 in 2022, then plunged by 68.62% to $107000.0 in 2023, then surged by 567.29% to $714000.0 in 2024, then surged by 35.29% to $966000.0 in 2025.
• Business Quant data shows XENE's Other Accumulated Expenses at $966000.0 in Q4 2025, $935000.0 in Q3 2025, and $439000.0 in Q2 2025.